Indaptus Therapeutics
New York
About Indaptus Therapeutics
Indaptus Therapeutics focuses on revolutionizing the treatment of cancer and certain infectious diseases. Its proprietary platform exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $49.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: nasdaq:INDP
- Website: indaptusrx.com
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/indaptus-therapeutics-103248 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.